Capital expenditure decreased 74.3%
Capital expenditure changed -74.3% from the comparable as-filed period. The change ranks at the 67th percentile of 6 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed -74.3% from the comparable as-filed period. The change ranks at the 67th percentile of 6 prior comparable changes.
Cash & equivalents changed +50.5% from the comparable as-filed period.
Free-cash-flow proxy changed +216.7% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Operating cash flow changed +166.7% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Stock-based compensation changed -33.3% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes.
Capex / revenue changed -105 basis points from the comparable as-filed period.
Inventory changed +5.6% from the comparable as-filed period.
Gross margin changed +42 basis points from the comparable as-filed period.
Gross profit changed +2.8% from the comparable as-filed period.
Net income changed +0.8% from the comparable as-filed period.
Operating income changed +2.3% from the comparable as-filed period.
Operating margin changed +11 basis points from the comparable as-filed period.
Revenue changed +1.5% from the comparable as-filed period.
Selling, general & administrative changed +3.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.